CPPCY yields 3.14% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, CPPCY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CPPCY + PFE for your $10,000?
CP ALL Public Company Limited, together with its subsidiaries, operates and franchises convenience stores under the 7-Eleven name to other retailers primarily in Thailand. It operates through three segments: Wholesale Business, Retail Business, and Management of Rental Spaces in Shopping Centers. The Wholesale Business segment engages in import, export, and distribution of frozen and chilled food with delivery services and focuses on selling consumer products, including fresh food, dry food, and consumer products under Makro brand. Its Retail Business segment is involved in domestic supply chain, distribution system, logistics network, and brand equity businesses. This segment also sells its products under various domestic, international, and small and medium enterprises brands. The company's Management of Rental Spaces in Shopping Centers segment manages buildings and retail spaces in shopping malls. In addition, the company is involved in sale and maintenance of retail equipment; cash and carry, catalog, and e-commerce businesses; marketing and advertising activities; provision of information technology and research and development services, as well as engaged in bill payment collection, life insurance, and non-life insurance broker business. Further, the company offers educational institution, training, business seminar services, as well as healthcare and medical specialist's consultation services. As of December 31, 2021, CP ALL Public Company Limited operated 13,134 stores. The company was formerly known as C.P. Seven Eleven Public Company Limited. CP ALL Public Company Limited was founded in 1988 and is headquartered in Bangkok, Thailand.
Full CPPCY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.